Searches were made using the National Library of Medicine Pubmed database. Search criteria were, individually and in combination: “Crohn”, “Crohn's”, “Johne's”, “paratuberculosis”, and “paratuberculosis and milk”. English language articles and English translations of abstracts in other languages were reviewed. Websites were identified using Google and the website of the International Paratuberculosis Association (http://www.paratuberculosis.org).
ReviewIs Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease
Section snippets
Mycobacteria are effective pathogens
Mycobacterium tuberculosis infects about one-third of humankind today.20 However, only an estimated 5–10% of those exposed have a lifetime risk of developing active tuberculosis.21 An even smaller minority of those who are infected are killed by the disease.22 Nevertheless, M tuberculosis has killed about one billion people over the past two centuries.23 I suggest that MAP is an equally effective and even more insidious pathogen than M tuberculosis. It infects many species and yet, in human
MAP in the environment and in animals
MAP is found in the potable water supply of large cities in industrialised nations.24 Mycobacteria are at least two orders of magnitude more resistant to chlorine purification than Escherichia coli.25 MAP survives higher concentrations of chlorine (two parts per million) than the 1·1 parts per million routinely achieved with first-use municipal water in the USA.26 Additionally, mycobacteria are more resistant to chlorine purification at the low-nutrient, low-temperature, and increased-pH
MAP in milk
MAP in milk from domestic animals is well described,40, 41, 42, 43, 44 and it is not reproducibly eradicated by pasteurisation at the parameters routinely used in the USA.15, 45, 46, 47, 48, 49 There are concerns that using pasteurisation standards effective against MAP may adversely effect the taste and, therefore, consumer acceptance of milk products.15
MAP has been cultured from the milk of two women with active Crohn's disease who were breast feeding.50 Identification was confirmed by the
Pathogenicity of MAP in human beings
The dogma that MAP is not a zoonotic organism—ie, that it is not pathogenic in human beings—is challenged by two case reports. A 36-year-old patient with haemophilia, AIDS, and a CD4+ lymphocyte count of 29 × 106/mL developed vicious diarrhoea. Acid-fast bacilli were seen in biopsy samples from his colon, liver, and bone marrow. Uniquely in human beings, these cell-wall-containing mycobacteria were identified as MAP by both culture (requiring mycobactin containing medium) and IS900 DNA analysis.
Ziehl-Neelsen staining for MAP
Both of the publications that identified Crohn's disease1, 2 commented on a major difference between the disease they were describing and intestinal tuberculosis: a lack of identifiable acid-alcohol-fast-staining bacteria by the technique described by Ziehl and Neelsen in 1886.55 This staining method identifies the complex and characteristic cell wall of intact mycobacteria. The major difference between Crohn's disease and Johne's disease is that the causative organism can be seen in some
Growing MAP in vitro
Part of the problem in diagnosing MAP infections in human beings may be due to the difficulty of growing MAP in vitro.60, 71 In part the culture problem is due to the fact that MAP lacks the iron-chelating agent mycobactin. As a consequence, either the infected host or the culture medium must provide the MAP with iron for it to grow. Achieving growth may be even more difficult when the organism is initially in its cell-wall-deficient form.56, 57 Although culturing MAP is difficult, it is not
Isolating the DNA and RNA of MAP
The DNA sequence IS900, first identified in 1989,51 is considered the “gold standard” to differentiate MAP from other mycobacteria.41, 42, 43, 50, 51, 52, 54, 59, 64, 66, 67, 74, 75, 76, 77, 78, 79, 80 It must be emphasised that the mere presence of IS900 DNA is not pathognomonic of a causal relation between Crohn's disease and MAP. Importantly, the isolation of DNA of MAP from patients with Crohn's disease is not reproducible. In my laboratory, although we identified the RNA of MAP in 100% of
Koch's postulates may have been met for MAP and Crohn's disease
Although M leprae has not fulfilled the second, third, or fourth postulate of Koch as the cause of leprosy,73 because the organism cannot be grown in vitro, few would dispute the statement that leprosy is an infectious disease caused by M leprae.
Unlike M leprae, MAP can be grown in vitro, albeit with the considerable difficulty previously described.60, 71 I suggest that Koch's four postulates102 may already have been met for MAP and Crohn's disease.103 To accept this claim presupposes that
Clinical trials of antibiotics to treat Crohn's disease
Published material is replete with negative studies that have attempted to treat Crohn's disease with antibiotics.111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125 Importantly, in all these studies the antibiotics used were ineffective against the avium species of mycobacteria in general, and MAP in particular. I suggest that studies to treat Crohn's disease with antibiotics that have no activity against M avium and MAP are meaningless if the causative organism of
Comparisons among leprosy, tuberculosis, Johne's disease, and Crohn's disease
It is conceptually helpful to compare the clinical manifestations of three well-described mycobacterial diseases—leprosy, tuberculosis, and Johne's disease—with Crohn's disease. All four diseases under consideration have multiple clinical manifestations.
Possibly recognised in antiquity, leprosy has two distinct clinical manifestations (figure 2), which were designated by Hansen in 1874136 as the “tuberculoid” and “lepromatous” forms. M leprae is the organism that causes both the lepromatous and
Intestinal obstruction during antibiotic therapy for tuberculosis and Crohn's disease
Usually, during the course of a clinical trial involving medications, progression to surgery is interpreted as indicating a failure of therapy. To the contrary, I suggest that in tuberculosis as well as in Crohn's disease progression to intestinal obstruction may actually indicate a positive, albeit a paradoxical, clinical response.
One-third of patients with intestinal tuberculosis who receive appropriate anti-M tuberculosis therapy may require additional surgery to relieve intestinal
Crohn's and tuberculosis susceptibility to genetic defects
The presence of a gene that is associated with an increased susceptibility to develop a disease does not preclude the possibility that the disease may be infectious in aetiology. A genetic defect has been identified that suggests that black people are more susceptible to tuberculosis than other races.145 Similarly, an increased susceptibility to Crohn's disease, but not ulcerative colitis,132 is associated with a defect in the NOD2 gene132, 133, 134 It is of interest that the NOD2 gene
Immune modulation and the therapy of tuberculosis and Crohn's disease
Clinical responses to immune modulation have been reported in the therapy of Crohn's disease,146, 147 particularly the more aggressive perforating form.147 In the event that Crohn's disease is eventually accepted to be infectious in aetiology, this paradox of clinical improvement of an infectious disease by immune modulation will need to be fully explained. Again it is of use to compare Crohn's disease with tuberculosis. Although tuberculosis is incontrovertibly infectious, encouraging results
Conclusions and recommendations
There are increasingly compelling data that MAP, a major cause of disease in agricultural, domestic, and wild animals, may be responsible for much more disease in humans than has been recognised. Appropriate ethical, prospective, randomised studies, are indicated among patients with Crohn's disease. These studies should use multiple antibiotics that are active against the avium species of mycobacteria. The duration of therapy needs to be determined. Individuals with NOD2 defects may require
Search strategy and selection criteria
References (148)
- et al.
Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival
Gastroenterology
(1998) - et al.
Epidemiology of paratuberculosis in wild ruminants studied by restriction fragment length polymorphism in the Czech Republic during the period 1995–1998
Vet Microbiol
(2000) - et al.
Farm factors associated with the presence of Mycobacteriumparatuberculosis infection in dairy herds on the New York State Paratuberculosis Control Program
Prev Vet Med
(1997) Transmission of paratuberculosis
Vet Clin North Am Food Anim Pract
(1996)- et al.
Incidence of Mycobacteriumparatuberculosis in raw sheep and goats' milk in England, Wales and Northern Ireland
Vet Microbiol
(2001) Mycobacteriumparatuberculosis: a potential food-borne pathogen?
J Dairy Sci
(1997)- et al.
Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients
Am J Gastroenterol
(2000) - et al.
Use of short-term culture for identification of Mycobacterium avium subsp. paratuberculosis in tissue from Crohn's disease patients
Clin Microbiol Infect
(2000) - et al.
Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis
Vet Microbiol
(2000) - et al.
Identification of cell wall deficient forms of M. avium subsp. paratuberculosis in paraffin embedded tissues from animals with Johne's disease by in situ hybridization
J Microbiol Methods
(2000)
In situ identification of mycobacteria in Crohn's disease patient tissue using confocal scanning laser microscopy
Mol Cell Probes
Use of four DNA insertion sequences to characterize strains of the Mycobacterium avium complex isolated from animals
Mol Cell Probes
Polymorphisms in IS1311, an insertion sequence common to Mycobacterium avium and M. avium subsp. paratuberculosis, can be used to distinguish between and within these species
Mol Cell Probes
Solid-phase hybridization capture of low-abundance target DNA sequences: application to the polymerase chain reaction detection of Mycobacteriumparatuberculosis and Mycobacterium avium subsp silvaticum
Anal Biochem
Control of messenger RNA stability in higher eukaryotes
Trends Genet
Chronic intestinal enteritis
BMJ
Regional ileitis
JAMA
Incidence of Crohn's disease in Olmsted County, Minnesota, 1935-1975
Am J Epidemiol
A clustering of Crohn's disease in Mankato, Minnesota
Inflamm Bowel Dis
Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study
Am J Epidemiol
Epidemiology of Crohn's disease in the Jewish population of central Israel, 1970–1980
Am J Gastroenterol
Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962–87: a sixfold increase in incidence
Scand J Gastroenterol
Early environmental factors may have role in both Crohn's disease and gastric carcinoma
BMJ
Lack of support for a common etiology in Johne's disease of animals and Crohn's disease in humans
Inflamm Bowel Dis
Etiological role of mycobacterium in Crohn's disease: an assessment of the literature
Dig Dis
Crohn disease: uncertainty about the etiologic role of Mycobacteriumparatuberculosis
Bull Acad Natl Med
Inflammatory bowel disease
N Engl J Med
Dictionary of medical eponyms
Advisory Committee on Microbiological Safety of Food. Heat resistance of Mycobacterium avium subsp paratuberculosis in milk at pasteurisation temperatures [ACM486]
Food Safety Authority of Ireland: Mycobacterium paratuberculosis: does it contribute to Crohn's Disease? Dublin: Food Safety Authority of Ireland, 2001
Advisory Committee on Microbiological Safety of Food: Mycobacterium avium subspecies paratuberculosis and Crohn's disease [ACM493]
Possible links between Crohn's disease and paratuberculosis
Advisory Committee on Microbiological Safety of Food. Mycobacterium avium subspecies paratuberculosis: review of advice [ACM487]
Management of tuberculosis in the United States
N Engl J Med
Innate immunity to Mycobacteriumtuberculosis
Clin Microbiol Rev
The major infectious diseases in the world—to treat or not to treat?
N Engl J Med
Consumption, the great killer
Modern Drug Discovery
On the etiology of Crohn disease
Proc Natl Acad Sci USA
Chlorine disinfection of atypical mycobacteria isolated from a water distribution system
Appl Environ Microbiol
Bactericidal effect of chlorine on Mycobacteriumparatuberculosis in drinking water
Lett Appl Microbiol
Ein eigenthumlicher fall von tuberculose beim rind [A particular case of tuberculosis in a cow]
Dtsch Zeitschr Tiermed Vergl Pathol
Mycobacteriumparatuberculosis infection in a colony of stumptail macaques (Macaca arctoides)
J Infect Dis
Epidemiological study of paratuberculosis in wild rabbits in Scotland
J Clin Microbiol
Paratuberculosis infection of nonruminant wildlife in Scotland
J Clin Microbiol
Pathology of spontaneous and experimental infection of North American wild ruminants with Mycobacterium paratuberculosis
Vet Pathol
The pathology of spontaneous paratuberculosis in the North American bison (Bison bison)
Vet Pathol
Paratuberculosis in saiga antelope (Saiga tatarica) and experimental transmission to domestic sheep
JWildl Dis
Bacterial studies on the occurrence of Mycobacterium paratuberculosis in fecal samples of zoo ruminants
Berl Munch Tierarztl Wochenschr
Control of Mycobacterium avium subsp paratuberculosis infection in agricultural species
Rev Sci Tech
Dire warnings about Johne's disease. Awake up call to the dairy industry?
Wisconsin Agriculturist
Cited by (276)
Gut microbiome dysbiosis in inflammatory bowel disease
2022, Progress in Molecular Biology and Translational ScienceFactors influencing the effectiveness of the Gudair vaccine for controlling Johne's disease in sheep flocks in Australia
2021, Preventive Veterinary MedicinePancreatic anti-GP2 and anti-Saccharomyces cerevisiae antibodies in ruminants with paratuberculosis: A better understanding of the immunopathogenesis of Crohn's disease
2020, Clinics and Research in Hepatology and GastroenterologyProfiling of Mycobacterium avium subspecies paratuberculosis in the milk of lactating goats using antigen-antibody based assays
2019, Comparative Immunology, Microbiology and Infectious DiseasesChronic regional intestinal inflammatory disease: A trans-species slow infection?
2019, Comparative Immunology, Microbiology and Infectious DiseasesCitation Excerpt :This seminal paper led to the coining of the Crohn´s disease eponym and its quick worldwide acceptance. After that, many studies and findings have been published along the years [30,31], of which the more relevant to this paper approach are included in Table 1 [7,24,25,27,28,32–51]. The incidence of human IBD has been increasing worldwide during the last century, but it seems to have stabilized now [2].